Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome.
Ferraguto C, Piquemal-Lagoueillat M, Lemaire V, Moreau MM, Trazzi S, Uguagliati B, Ciani E, Bertrand SS, Louette E, Bontempi B, Pietropaolo S.
Ferraguto C, et al. Among authors: lemaire v.
Neuropsychopharmacology. 2024 Dec;49(13):2032-2041. doi: 10.1038/s41386-024-01956-6. Epub 2024 Sep 2.
Neuropsychopharmacology. 2024.
PMID: 39223257